Silexion Therapeutics shareholders approve 6x increase in authorized shares to 9M

Silexion Therapeutics Corp

Authorized capital raised from US$20,000 (1,481,482 shares) to US$121,500 (9,000,000 shares).
Vote results: 699,871 for (59.8%), 470,828 against (40.2%), 289,225 abstentions.
Meeting originally Aug 12, 2025, reconvened Aug 19 after no quorum; 16.8% of shares present constituted quorum under Articles.
Memorandum Amendment filed and effective in Cayman Islands on August 19, 2025.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Silexion Therapeutics Corp: Increased authorized share capital via amendment to memorandum of association (effective 2025-08-19).

Change: charter amendment
Effective: 2025-08-19

Exact text from the filing

the shareholders of the Company duly approved a resolution serving as an effective amendment to paragraph 5 of the Company’s amended and restated memorandum of association (the “ Memorandum Amendment”) , which increased the Company's authorized share capital

View on SEC.gov

51 governance changes filed in the last 30 days. Browse all governance changes →

Silexion Therapeutics Corp filing history →

Source: SEC EDGAR

accession 0001178913-25-002985

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.